Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant
is highly transmissible with potential immune escape. We conducted a test-negative case–…

Objectives To evaluate the effectiveness of the mRNA-1273 vaccine against SARS-CoV-2
variants and assess its effectiveness against the delta variant by time since vaccination. …

Studies have reported reduced natural SARS-CoV-2 infection- and vaccine-induced
neutralization against omicron BA.4/BA.5 compared with earlier omicron subvariants. This test-…

Background Globally, recommendations are expanding for third (booster) doses of
BNT162b2 (Pfizer–BioNTech). In the United States, as of November 19, 2021, boosters were …

Background Phase 3 trials found mRNA-1273 was highly effective in preventing COVID-19.
We conducted a prospective cohort study at Kaiser Permanente Southern California (KPSC) …

The bivalent (original and Omicron BA.4/BA.5) mRNA-1273 COVID-19 vaccine was authorized
to offer broader protection against COVID-19. We conducted a matched cohort study to …

Studies have reported reduced natural SARS-CoV-2 infection- and vaccine-induced
neutralization against Omicron BA.4/BA.5 compared with earlier Omicron subvariants. We …

Background Reports of perforation risk related to intrauterine devices (IUDs) inserted immediately
post partum and among non-post-partum individuals are scarce, and previous studies …

Background Real-world studies have found high vaccine effectiveness (VE) of mRNA-based
COVID-19 vaccines, but reduced VE against the Delta variant and waning protection have …

Importance Intrauterine device (IUD) expulsion increases the risk of unintended pregnancy;
how timing of postpartum IUD insertion and breastfeeding are associated with risk of …